Literature DB >> 2814489

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.

M D Howell1, S T Winters, T Olee, H C Powell, D J Carlo, S W Brostoff.   

Abstract

Experimental allergic encephalomyelitis (EAE) is an autoimmune disease of the central nervous system mediated by CD4+ T cells reactive with myelin basic protein (MBP). Rats were rendered resistant to the induction of EAE by vaccination with synthetic peptides corresponding to idiotypic determinants of the beta chain VDJ region and J alpha regions of the T cell receptor (TCR) that are conserved among encephalitogenic T cells. These findings demonstrate the utility of TCR peptide vaccination for modulating the activity of autoreactive T cells and represent a general therapeutic approach for T cell-mediated pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2814489     DOI: 10.1126/science.2814489

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  76 in total

1.  Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system.

Authors:  D Gestri; L Baldacci; R Taiuti; E Galli; E Maggi; M P Piccinni; M Vergelli; L Massacesi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 2.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 3.  Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination.

Authors:  A W Lohse; I R Cohen
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  Approaches toward peptide-based immunotherapy of autoimmune diseases.

Authors:  L Adorini; J C Guéry; S Trembleau
Journal:  Springer Semin Immunopathol       Date:  1992

5.  T-cell-receptor dose and the time of treatment during murine retrovirus infection for maintenance of immune function.

Authors:  B Liang; S Ardestani; J J Marchalonis; R R Watson
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 6.  Homeostatic control of immunity by TCR peptide-specific Tregs.

Authors:  Vipin Kumar
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

7.  Characterization of a single-chain T-cell receptor expressed in Escherichia coli.

Authors:  W F Hoo; M J Lacy; L K Denzin; E W Voss; K D Hardman; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

8.  Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Authors:  S D Sharma; B Nag; X M Su; D Green; E Spack; B R Clark; S Sriram
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.

Authors:  C M Meyers; C J Kelly
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease.

Authors:  R Gold; G Giegerich; H P Hartung; K V Toyka
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.